1	Sandoz	_	NNP	_	_	2	NAME	_	_
2	AG	_	NNP	_	_	12	SBJ	_	_
3	,	_	,	_	_	2	P	_	_
4	a	_	DT	_	_	10	NMOD	_	_
5	major	_	JJ	_	_	10	NMOD	_	_
6	Swiss	_	NNP	_	_	10	NMOD	_	_
7	chemical	_	NN	_	_	10	NMOD	_	_
8	and	_	CC	_	_	7	COORD	_	_
9	pharmaceutical	_	JJ	_	_	8	CONJ	_	_
10	group	_	NN	_	_	2	APPO	_	_
11	,	_	,	_	_	2	P	_	_
12	said	_	VBD	_	_	0	ROOT	_	_
13	that	_	DT	_	_	12	OBJ	_	_
14	its	_	PRP$	_	_	16	NMOD	_	_
15	group	_	NN	_	_	16	NMOD	_	_
16	sales	_	NNS	_	_	17	SBJ	_	_
17	rose	_	VBD	_	_	13	SUB	_	_
18	25	_	CD	_	_	19	NMOD	_	_
19	%	_	NN	_	_	17	EXT	_	_
20	to	_	TO	_	_	17	DIR	_	_
21	9.482	_	CD	_	_	22	DEP	_	_
22	billion	_	CD	_	_	23	NMOD	_	_
23	francs	_	NNS	_	_	20	PMOD	_	_
24	(	_	(	_	_	25	P	_	_
25	$	_	$	_	_	23	PRN	_	_
26	5.80	_	CD	_	_	25	DEP	_	_
27	billion	_	CD	_	_	25	DEP	_	_
28	)	_	)	_	_	25	P	_	_
29	in	_	IN	_	_	17	TMP	_	_
30	the	_	DT	_	_	33	NMOD	_	_
31	first	_	JJ	_	_	33	NMOD	_	_
32	nine	_	CD	_	_	33	NMOD	_	_
33	months	_	NNS	_	_	29	PMOD	_	_
34	of	_	IN	_	_	33	NMOD	_	_
35	this	_	DT	_	_	36	NMOD	_	_
36	year	_	NN	_	_	34	PMOD	_	_
37	,	_	,	_	_	17	P	_	_
38	with	_	IN	_	_	17	ADV	_	_
39	strong	_	JJ	_	_	40	NMOD	_	_
40	gains	_	NNS	_	_	38	PMOD	_	_
41	in	_	IN	_	_	40	LOC	_	_
42	all	_	DT	_	_	43	NMOD	_	_
43	divisions	_	NNS	_	_	41	PMOD	_	_
44	.	_	.	_	_	12	P	_	_

1	A	_	DT	_	_	2	NMOD	_	_
2	year	_	NN	_	_	3	AMOD	_	_
3	earlier	_	JJR	_	_	5	TMP	_	_
4	sales	_	NNS	_	_	5	SBJ	_	_
5	totaled	_	VBD	_	_	0	ROOT	_	_
6	7.567	_	CD	_	_	7	DEP	_	_
7	billion	_	CD	_	_	8	NMOD	_	_
8	francs	_	NNS	_	_	5	OBJ	_	_
9	.	_	.	_	_	5	P	_	_

1	Positive	_	JJ	_	_	3	NMOD	_	_
2	currency	_	NN	_	_	3	NMOD	_	_
3	rates	_	NNS	_	_	8	SBJ	_	_
4	and	_	CC	_	_	3	COORD	_	_
5	strong	_	JJ	_	_	7	NMOD	_	_
6	sales	_	NNS	_	_	7	NMOD	_	_
7	growth	_	NN	_	_	4	CONJ	_	_
8	led	_	VBD	_	_	0	ROOT	_	_
9	to	_	TO	_	_	8	ADV	_	_
10	a	_	DT	_	_	12	NMOD	_	_
11	substantial	_	JJ	_	_	12	NMOD	_	_
12	rise	_	NN	_	_	9	PMOD	_	_
13	in	_	IN	_	_	12	LOC	_	_
14	consolidated	_	JJ	_	_	15	NMOD	_	_
15	profit	_	NN	_	_	13	PMOD	_	_
16	in	_	IN	_	_	8	TMP	_	_
17	the	_	DT	_	_	18	NMOD	_	_
18	period	_	NN	_	_	16	PMOD	_	_
19	,	_	,	_	_	8	P	_	_
20	although	_	IN	_	_	8	ADV	_	_
21	the	_	DT	_	_	22	NMOD	_	_
22	company	_	NN	_	_	23	SBJ	_	_
23	did	_	VBD	_	_	20	SUB	_	_
24	n't	_	RB	_	_	23	ADV	_	_
25	provide	_	VB	_	_	23	VC	_	_
26	figures	_	NNS	_	_	25	OBJ	_	_
27	,	_	,	_	_	25	P	_	_
28	as	_	IN	_	_	25	ADV	_	_
29	is	_	VBZ	_	_	28	SUB	_	_
30	customary	_	JJ	_	_	29	PRD	_	_
31	with	_	IN	_	_	29	ADV	_	_
32	Swiss	_	NNP	_	_	33	NMOD	_	_
33	companies	_	NNS	_	_	31	PMOD	_	_
34	.	_	.	_	_	8	P	_	_

1	Sandoz	_	NNP	_	_	2	SBJ	_	_
2	said	_	VBD	_	_	0	ROOT	_	_
3	it	_	PRP	_	_	4	SBJ	_	_
4	expects	_	VBZ	_	_	2	OBJ	_	_
5	a	_	DT	_	_	8	NMOD	_	_
6	``	_	``	_	_	8	P	_	_
7	substantial	_	JJ	_	_	8	NMOD	_	_
8	increase	_	NN	_	_	4	OBJ	_	_
9	''	_	''	_	_	8	P	_	_
10	in	_	IN	_	_	8	LOC	_	_
11	consolidated	_	JJ	_	_	12	NMOD	_	_
12	profit	_	NN	_	_	10	PMOD	_	_
13	for	_	IN	_	_	8	TMP	_	_
14	the	_	DT	_	_	16	NMOD	_	_
15	full	_	JJ	_	_	16	NMOD	_	_
16	year	_	NN	_	_	13	PMOD	_	_
17	,	_	,	_	_	4	P	_	_
18	barring	_	VBG	_	_	4	SBJ	_	_
19	major	_	JJ	_	_	22	NMOD	_	_
20	currency	_	NN	_	_	22	NMOD	_	_
21	rate	_	NN	_	_	22	NMOD	_	_
22	changes	_	NNS	_	_	18	OBJ	_	_
23	.	_	.	_	_	2	P	_	_

